Delivery Order SPE2DB22D1017-SPE2DB24FG5VF

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,708.02, is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 medication in 60-count units. The $29,677.67 Firm Fixed Price delivery order contract has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,105.04 contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a prescription medication. The contract has no set-aside designation and will run through September 16, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, collectively valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.26 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,139.46, is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,494.13 firm fixed-price contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,336.61 firm fixed-price contract is for the provision of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta (100-62.5-25) inhalation product. The order is valued at $3,922.33 and has an ultimate completion date of September 6, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $25,986.43, is for the delivery of 4,563,430,910 units of the medication Trelegy Ellipta 100-62.5-25 60S. The contract is a Firm Fixed Price Delivery Order with a completion date of January 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60s medication. The contract, valued at $26,860.44, has an ultimate completion date of August 26, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these prescription drugs to support military treatment...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5VF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,286.28 firm fixed-price contract is for the supply of 4,565,941,038 units of the medication Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of September 26, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. This specific award does not have a set-aside designation.

Generated 12/25/24, 9:11 AM